TRAVERSA SERGIO 内部人交易：近期 SEC Form 4 交易
过去 18 个月，TRAVERSA SERGIO（CIK 1565832）在 1 家公司共报告 10 笔 SEC Form 4 内部人交易（最近一笔 2026-09-11）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-11 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 100,000 | $418,000 |
| 2026-09-11 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 100,000 | $410,000 |
| 2025-12-16 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 27,500 | $113,300 |
| 2025-11-06 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 272,500 | $599,500 |
| 2025-08-28 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 80,545 | $49,938 |
| 2025-08-28 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 129,455 | $86,735 |
| 2025-08-28 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 55,976 | $41,422 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 172,314 | $77,541 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 30,000 | $15,000 |
| 2025-05-20 | RELMADA THERAPEUTICS, INC. (RLMD) | Chief Executive Officer | 买入 | 147,686 | $82,704 |
来源：SEC Form 4 申报文件 · 截至 2026-09-11